This Article Full Text Full Text (PDF) All Versions of this Article: 49/5/962    most recent HYPERTENSIONAHA.106.079426v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorn, G. W. Search for Related Content PubMed PubMed Citation Articles by Dorn, G. W., II Related Collections Structure Biochemistry and metabolism Congestive

(Hypertension. 2007;49:962.)
© 2007 American Heart Association, Inc.

Brief Reviews

The Fuzzy Logic of Physiological Cardiac Hypertrophy

From the Center for Molecular Cardiovascular Research, University of Cincinnati, Ohio.

Correspondence to Gerald W. Dorn II, Molecular Cardiovascular Research, University of Cincinnati, 231 Albert Sabin Way, ML 0839, Cincinnati, OH 45267-0839. E-mail dorngw@ucmail.uc.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Cardiac hypertrophy is defined as an abnormal increase in heart muscle mass and is functionally, mechanistically, and histologically distinguished from normal embryonic and postnatal myocardial growth by characteristic changes in cardiac myocyte shape and volume.¹ Reactive hypertrophy, that is, hypertrophy that occurs in response to an extrinsic increase in cardiac work,² is distinguished from genetic familial hypertrophic cardiomyopathy mutations³ in which the stimulus for hypertrophy is intrinsic to the cardiomyocyte. In the prototypical reactive hypertrophic response to pressure overload, decreased wall stress (estimated as the ratio of ventricular radius to wall thickness; Figure 1) resulting from "compensatory" cardiac hypertrophy provides mechanical advantages that help normalize ejection performance in the face of increased workload as originally described by Grossman et al⁴ (Figure 1). These mechanical benefits accrue whether the stimulus for hypertrophy is intermittent, as with exercise training that produces "physiological hypertrophy," or sustained, as with hypertension or aortic stenosis that produce "pathological hypertrophy." With sustained hemodynamic overload, however, progressive systolic dysfunction ultimately occurs that leads to heart failure (Figure 1). The realization that prolonged, continuous hemodynamic stress will ultimately lead to hypertrophy decompensation, together with accumulating information that the hypertrophied myocardium is transcriptionally and biochemically distinct from normal myocardium,⁵ lead Katz to derive the concept of a "cardiomyopathy of pressure overload,"⁶ which is a specific contextual application of the notion of pathological hypertrophy.

View larger version (15K):   Figure 1. Stimulus-specific hypertrophic responses of the heart and how they affect wall stress (c), which, at equal pressures, is proportional to . . . [Full Text of this Article]

This article has been cited by other articles:

				L. Zelarayan, A. Renger, C. Noack, M.-P. Zafiriou, C. Gehrke, R. van der Nagel, R. Dietz, L. de Windt, and M. W. Bergmann NF-{kappa}B activation is required for adaptive cardiac hypertrophy Cardiovasc Res, December 1, 2009; 84(3): 416 - 424. [Abstract] [Full Text] [PDF]

				C. M. McNicholas and K. H. Berecek Mammalian Target of Rapamycin: MasTOR Mediator of Cellular Changes in Pathological States? Hypertension, December 1, 2009; 54(6): 1221 - 1222. [Full Text] [PDF]

				D. Lachance, E. Plante, A.-A. Bouchard-Thomassin, S. Champetier, E. Roussel, M.-C. Drolet, M. Arsenault, and J. Couet Moderate Exercise Training Improves Survival and Ventricular Remodeling in an Animal Model of Left Ventricular Volume Overload Circ Heart Fail, September 1, 2009; 2(5): 437 - 445. [Abstract] [Full Text] [PDF]

				C. D. Garciarena, O. A. Pinilla, M. B. Nolly, R. P. Laguens, E. M. Escudero, H. E. Cingolani, and I. L. Ennis Endurance Training in the Spontaneously Hypertensive Rat: Conversion of Pathological into Physiological Cardiac Hypertrophy Hypertension, April 1, 2009; 53(4): 708 - 714. [Abstract] [Full Text] [PDF]

				J. Cai, F.-F. Yi, L. Yang, D.-F. Shen, Q. Yang, A. Li, A. K. Ghosh, Z.-Y. Bian, L. Yan, Q.-Z. Tang, et al. Targeted Expression of Receptor-Associated Late Transducer Inhibits Maladaptive Hypertrophy via Blocking Epidermal Growth Factor Receptor Signaling Hypertension, March 1, 2009; 53(3): 539 - 548. [Abstract] [Full Text] [PDF]

				M. W. Bergmann and L. Zelarayan RALT Specifically Halts Maladaptive Cardiac Hypertrophy: A New Kid on the Block Hypertension, March 1, 2009; 53(3): 454 - 455. [Full Text] [PDF]

				B. A. Rothermel and J. A. Hill Autophagy in Load-Induced Heart Disease Circ. Res., December 5, 2008; 103(12): 1363 - 1369. [Abstract] [Full Text] [PDF]

				J. Kim, A. R. Wende, S. Sena, H. A. Theobald, J. Soto, C. Sloan, B. E. Wayment, S. E. Litwin, M. Holzenberger, D. LeRoith, et al. Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy Mol. Endocrinol., November 1, 2008; 22(11): 2531 - 2543. [Abstract] [Full Text] [PDF]

				J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw Genomics in cardiac metabolism Cardiovasc Res, July 15, 2008; 79(2): 218 - 227. [Abstract] [Full Text] [PDF]

				J. A. Hill and E. N. Olson Cardiac Plasticity N. Engl. J. Med., March 27, 2008; 358(13): 1370 - 1380. [Full Text] [PDF]

				A. Diwan, J. Wansapura, F. M. Syed, S. J. Matkovich, J. N. Lorenz, and G. W. Dorn II Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation Circulation, January 22, 2008; 117(3): 396 - 404. [Abstract] [Full Text] [PDF]

				R. Q Osborn, W. C Taylor, K. Oken, M. Luzano, M. Heckman, and G. Fletcher Echocardiographic characterisation of left ventricular geometry of professional male tennis players Br. J. Sports Med., November 1, 2007; 41(11): 789 - 792. [Abstract] [Full Text] [PDF]